[HTML][HTML] Cancer-Specific Health Utilities: Evaluation of Core Measurement Properties of the EORTC QLU-C10D in Lung Cancer Patients—Data from Four Multicentre …

MJ Pilz, S Seyringer, I Al-Naesan, MT King… - PharmacoEconomics …, 2024 - Springer
Background Cost-utility analysis generally requires valid preference-based measures
(PBMs) to assess the utility of patient health. While generic PBMs are widely used, disease …

[HTML][HTML] Derivation of utility values from European Organization for Research and Treatment of Cancer Quality of Life-Core 30 questionnaire values in lung cancer

RW Jang, PK Isogai, N Mittmann, PA Bradbury… - Journal of Thoracic …, 2010 - Elsevier
Introduction Cancer clinical trials frequently incorporate quality of life (QoL) measures but
rarely patient utility. Utility information is required for cost utility evaluations of novel cancer …

[HTML][HTML] The EORTC QLU-C10D discrete choice experiment for cancer patients: a first step towards patient utility weights

EM Gamper, MT King, R Norman, FLC Loth… - Journal of patient …, 2022 - Springer
Abstract Background The European Organisation for Research and Treatment of Cancer
(EORTC) Quality of Life Utility-Core 10 Dimensions (QLU-C10D) is a novel cancer-specific …

[HTML][HTML] The European Organisation for Research and Treatment of Cancer Quality of Life Utility-Core 10 Dimensions: Development and Investigation of General …

MJ Pilz, S Nolte, G Liegl, M King, R Norman… - Value in Health, 2023 - Elsevier
Abstract Objectives The European Organisation for Research and Treatment of Cancer
Quality of Life Utility-Core 10 Dimensions (EORTC QLU-C10D) is a cancer-specific …

[HTML][HTML] Dutch utility weights for the EORTC cancer-specific utility instrument: the Dutch EORTC QLU-C10D

F Jansen, IM Verdonck-de Leeuw, E Gamper… - Quality of Life …, 2021 - Springer
Purpose To measure utilities among cancer patients, a cancer-specific utility instrument
called the European Organization for Research and Treatment of Cancer (EORTC) QLU …

Health state utility values in advanced non-small cell lung cancer patients

J Chevalier, K Le Lay… - Value in Health, 2013 - valueinhealthjournal.com
Objectives Lung cancer has an important impact on Health related Quality of Life (HRQoL).
LUCEOR2 is a multi-country prospective study which aimed to measure HRQoL and EQ-5D …

[HTML][HTML] The EORTC QLU-C10D is a valid cancer-specific preference-based measure for cost-utility and health technology assessment in the Netherlands

MJ Pilz, S Seyringer, LR Hallsson, A Bottomley… - The European Journal of …, 2024 - Springer
Background Cost-utility analysis typically relies on preference-based measures (PBMs).
While generic PBMs are widely used, disease-specific PBMs can capture aspects relevant …

[HTML][HTML] Australian utility weights for the EORTC QLU-C10D, a multi-attribute utility instrument derived from the cancer-specific quality of life questionnaire, EORTC …

MT King, R Viney, A Simon Pickard, D Rowen… - …, 2018 - Springer
Abstract Background The EORTC QLU-C10D is a new multi-attribute utility instrument
derived from the widely used cancer-specific quality-of-life (QOL) questionnaire, EORTC …

The use of disease-specific outcome measures in cost-utility analysis: the development of Dutch societal preference weights for the FACT-L scale

LM Lamers, CAU Groot, I Buijt - Pharmacoeconomics, 2007 - Springer
Abstract Introduction The Functional Assessment of Cancer Therapy-Lung (FACT-L) is a
validated, sensitive and reliable patient questionnaire that evaluates and quantifies quality …

Mapping the QLQ-C30 quality of life cancer questionnaire to EQ-5D patient preferences

R Crott, A Briggs - The European journal of health economics, 2010 - Springer
Abstract Background Although cancer-specific Health-Related Quality of Life (HRQOL) are
commonly included in randomized clinical trials or other prospective non-randomized …